Volume 23, Issue 1 (January- February 2024)
Payesh 2024, 23(1): 19-34 |
Back to browse issues page
Ethics code: IR-TUMS.SPH.REC.1399.1075
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mosadeghrad A, Darrudi A, Karimi F. Health care pricing and tariff setting methods: A scoping review. Payesh 2024; 23 (1) :19-34
URL: http://payeshjournal.ir/article-1-2162-en.html
URL: http://payeshjournal.ir/article-1-2162-en.html
1- School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2- National Center for Health Insurance Research, Iran Health insurance, Tehran,
2- National Center for Health Insurance Research, Iran Health insurance, Tehran,
Abstract: (3000 Views)
Objective (s): Health services tariff is “the mandated price of health services determined by authorities and must be paid to healthcare providers in exchange of receiving services”. The pricing and tariff-setting system of healthcare services in Iran is facing challenges. This study aimed to identify and explain healthcare pricing and tariff-setting methods.
Methods: This study was conducted in 2023. Five English databases (i.e., PubMed, Web of Science, Scopus, Embase, and ProQuest) and three Persian databases (i.e., Magiran, Iranmedex and SID) and Google and Google scholar search engines were searched to find scientific sources. Finally, 45 documents related to healthcare pricing and tariff-setting methods were selected and analyzed using MAXQDA software version 10.
Results: Overall, 20 healthcare pricing and tariff setting methods were identified, including capitation, per diem, fee-for-service, global budget, negotiation-based, resource-based relative value scale, cost-plus, value-based, pay-for-performance, best practice-based, diagnosis-related groups, bundled, reference, tiered, sliding-scale, premium, market-based, risk-adjusted, subscription and competitive bidding. Each of these pricing and tariff-setting methods has advantages and disadvantages. In general, the prospective and fixed pricing methods reduce healthcare costs and increase the efficiency of healthcare organizations. The use of complementary value and performance based methods improve the quality of health services.
Conclusion: Health care pricing and tariff-setting methods affect access to health services, and quality and cost of health services. The capitation method along with the value and performance based methods are suggested for the pricing of outpatient services; and diagnosis related groups, bundled and best performance-based methods are suggested for the pricing of inpatient services in Iran.
Methods: This study was conducted in 2023. Five English databases (i.e., PubMed, Web of Science, Scopus, Embase, and ProQuest) and three Persian databases (i.e., Magiran, Iranmedex and SID) and Google and Google scholar search engines were searched to find scientific sources. Finally, 45 documents related to healthcare pricing and tariff-setting methods were selected and analyzed using MAXQDA software version 10.
Results: Overall, 20 healthcare pricing and tariff setting methods were identified, including capitation, per diem, fee-for-service, global budget, negotiation-based, resource-based relative value scale, cost-plus, value-based, pay-for-performance, best practice-based, diagnosis-related groups, bundled, reference, tiered, sliding-scale, premium, market-based, risk-adjusted, subscription and competitive bidding. Each of these pricing and tariff-setting methods has advantages and disadvantages. In general, the prospective and fixed pricing methods reduce healthcare costs and increase the efficiency of healthcare organizations. The use of complementary value and performance based methods improve the quality of health services.
Conclusion: Health care pricing and tariff-setting methods affect access to health services, and quality and cost of health services. The capitation method along with the value and performance based methods are suggested for the pricing of outpatient services; and diagnosis related groups, bundled and best performance-based methods are suggested for the pricing of inpatient services in Iran.
type of study: Systematic Reviw |
Subject:
Helath Services Management
Received: 2023/04/13 | Accepted: 2023/09/3 | ePublished ahead of print: 2023/11/11 | Published: 2023/12/27
Received: 2023/04/13 | Accepted: 2023/09/3 | ePublished ahead of print: 2023/11/11 | Published: 2023/12/27
References
1. Mosadeghrad AM. Why TQM does not work in Iranian healthcare organisations. International Journal of Health Care Quality Assurance 2014;27:320-35 [DOI:10.1108/IJHCQA-11-2012-0110]
2. Ellis RP, Martins B, Zhu W. Health care demand elasticities by type of service. Journal of Health Economics 2017;55:232-43 [DOI:10.1016/j.jhealeco.2017.07.007]
3. Mosadeghrad AM, Isfahani P, Karimi F. Hospital tariffs: A conceptual analysis. Hakim 2020; 23: 246-259
4. Mosadeghrad AM, Mirzaee N, Afshari M, Darrudi A. The impact of health transformation plan on health services fees. Tehran University Medical Journal 2018;76:277-82 [Persian]
5. World Health Organization. Global spending on health: rising to the pandemic's challenges. World Health Organization; 2022. Available at: https://www.who.int/publications/i/item/9789240064911 [Access date 09/09/2023]
6. Keliddar I, Mosadeghrad AM, Jafari-Sirizi M. Rationing in health systems: A critical review. Medical journal of the Islamic Republic of Iran 2017;31: 271-277 [DOI:10.14196/mjiri.31.47]
7. Barber SL, Lorenzoni L, Ong P. Price setting and price regulation in health care: lessons for advancing Universal Health Coverage. World Health Organization; 2019. Available at: https://iris.who.int/bitstream/handle/10665/325547/9789241515924-eng.pdf [Access date 06/11/2023] [DOI:10.1787/ed3c16ff-en]
8. Mosadeghrad AM, Darrudi A, Afshari M. Impact of health transformation plan on surgical and anesthesia procedures tariffs: A longitudinal study. Razi Journal of Medical Sciences 2019;25:17-32
9. Keyvanara M, Jabbari AR, Azizzadeh M. The challenges of the tariffs in medical services of health care system from the perspective of the managers of insurance agencies: A qualitative study. Hakim 2016; 19:13-24 [Persian]
10. Babashahy S, Rashidian A. Payments of physicians employed in public and private hospitals after modification of surgical and invasive services tariffs. Hakim Research Journal 2012;15:38-43 [Persian]
11. Moradi-Lakeh M, Vosoogh-Moghaddam A. Health sector evolution plan in Iran; equity and sustainability concerns. International Journal of Health Policy and Management 2015;4:637 [DOI:10.15171/ijhpm.2015.160]
12. Neyazi N, Mosadeghrad AM, Afshari M, Isfahani P and Safi N. Strategies to tackle non-communicable diseases in Afghanistan: A scoping review. Frontiers in Public Health 2023; 11: 1-15 [DOI:10.3389/fpubh.2023.982416]
13. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology 2005;8:19-32 [DOI:10.1080/1364557032000119616]
14. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in psychology 2006;3:77-101 [DOI:10.1191/1478088706qp063oa]
15. Waters HR, Hussey P. Pricing health services for purchasers-a review of methods and experiences. Health Policy 2004; 70: 175-184 [DOI:10.1016/j.healthpol.2004.04.012]
16. Lave JR, Frank RG. Effect of the structure of hospital payment on length of stay. Health Services Research 1990;25:327
17. Adida E, Mamani H, Nassiri S. Bundled payment vs. fee-for-service: Impact of payment scheme on performance. Management Science 2017;63:1606-24 [DOI:10.1287/mnsc.2016.2445]
18. Dowd BE, Laugesen MJ. Fee‐for‐service payment is not the (main) problem. Health Services Research 2020;55:491-495 [DOI:10.1111/1475-6773.13316]
19. Shih T, Chen LM, Nallamothu BK. Will bundled payments change health care? Examining the evidence thus far in cardiovascular care. Circulation 2015;131:2151-8 [DOI:10.1161/CIRCULATIONAHA.114.010393]
20. Huang Y, Liu Y, Yang X, Li J, Fang P. Global budget payment system helps to reduce outpatient medical expenditure of hypertension in China. SpringerPlus 2016; 5:1-7 [DOI:10.1186/s40064-016-3565-7]
21. Kutzin J. A descriptive framework for country-level analysis of health care financing arrangements. Health Policy 2001;56:171-204 [DOI:10.1016/S0168-8510(00)00149-4]
22. Barnum H, Kutzin J, Saxenian H. Incentives and provider payment methods. International Journal of Health Planning and Management 1995; 10:23-45 [DOI:10.1002/hpm.4740100104]
23. Rees R. Second-best rules for public enterprise pricing. Economica 1968; 35:260-73 [DOI:10.2307/2552302]
24. Burik D. The changing role of hospital prices: a framework for pricing in a competitive environment. Health Care Management Review 1983;8:65-72 [DOI:10.1097/00004010-198308020-00007]
25. Hsiao WC, Braun P, Dunn DL, Becker ER, Yntema D, Verrilli DK, Stamenovic E, Chen SP. An overview of the development and refinement of the resource-based relative value scale. Medical Care 1992; 30:NS1-NS12 [DOI:10.1097/00005650-199211001-00001]
26. Busse R. Priority-setting and rationing in German health care. Health Policy 1999; 50:71-90 [DOI:10.1016/S0168-8510(99)00065-2]
27. Harris-Shapiro J. RBRVS (Medicare Resource-Based Relative Value Scale) revisited. Journal of Health Care Finance 1998;25:49-54
28. Wiley M. Costing Hospital Case-Mix: The European Experience. In Casas M, Wiley M, editors. Diagnosis Related Groups in Europe. 1st Editon, Springer-Verlag: Berlin, 1993 [DOI:10.1007/978-3-642-78472-9_9]
29. Tan SS, Serdén L, Geissler A, van Ineveld M, Redekop K, Heurgren M, Hakkaart-van Roijen L. DRGs and cost accounting: which is driving which? In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis-Related Groups in Europe. 1st Edition, New York: Open University Press: New York, 2011
30. Baxter PE, Hewko SJ, Pfaff KA, Cleghorn L, Cunningham BJ, Elston D, Cummings GG. Leaders' experiences and perceptions implementing activity-based funding and pay-for-performance hospital funding models: A systematic review. Health Policy 2015;119:1096-110 [DOI:10.1016/j.healthpol.2015.05.003]
31. Mannion R, Marini G, Street A. Implementing payment by results in the English NHS: changing incentives and the role of information. Journal of Health Organization and Management 2008;22:79-88 [DOI:10.1108/14777260810862425]
32. Casalino LP, Elster A, Eisenberg A, Lewis E, Montgomery J, Ramos D. Will pay-for-performance and quality reporting affect health care disparities? Health Affairs 2007;26:405-14 [DOI:10.1377/hlthaff.26.3.w405]
33. Epstein AM, Lee TH, Hamel MB. Paying physicians for high-quality care. The New England Journal of Medicine 2004;350:406-10 [DOI:10.1056/NEJMsb035374]
34. Gershlick B. Best Practice Tariffs. 1st Edition, UK: The Health Foundation: Uk, 2016
35. Böcking W, Trojanus D. Diagnosis related groups. Encyclopedia of Public Health.. 1st Edition, Springer: Dordrecht, 2008 [DOI:10.1007/978-1-4020-5614-7_790]
36. Sorenson C, Drummond M, Torbica A, Callea G, Mateus C. The role of hospital payments in the adoption of new medical technologies: an international survey of current practice. Health Economics, Policy and Law 2015;10:133 [DOI:10.1017/S1744133114000358]
37. Mihailovic N, Kocic S, Jakovljevic M. Review of diagnosis-related group-based financing of hospital care. Health Services Research and Managerial Epidemiology 2016;3:2333392816647892 [DOI:10.1177/2333392816647892]
38. Horowitz JL, Kleiman MA. Advanced pricing strategies for hospitals in contracting with managed care organizations. The Journal of Ambulatory Care Management 1994;17:8-17 [DOI:10.1097/00004479-199401000-00004]
39. Miller HD. From volume to value: better ways to pay for health care. Health Affairs 2009;28:1418-28 [DOI:10.1377/hlthaff.28.5.1418]
40. Robinson JC, Brown TT. Increases in consumer cost sharing redirect patient volumes and reduce hospital prices for orthopedic surgery. Health Affairs 2013;32:1392-7 [DOI:10.1377/hlthaff.2013.0188]
41. Nassiri S, Adida E, Mamani H. Reference pricing for healthcare services. Manufacturing & Service Operations Management 2022;24:921-37 [DOI:10.1287/msom.2021.0986]
42. U.S. Department of Health & Human Services. Medicare: Opportunities for Market-Based Policies. Office of the Assistant Secretary for Planning and Evaluation. Available at: https://aspe.hhs.gov/sites/default/files/migrated_legacy_files/198096/eo-report-medicare-competition.pdf [Access date 13/08/2023]
43. Plahte J. Tiered pricing of vaccines: a win-win-win situation, not a subsidy. The Lancet Infectious Diseases 2005;5:58-63 [DOI:10.1016/S1473-3099(04)01255-1]
44. Malueg DA, Schwartz M. Parallel imports, demand dispersion, and international price discrimination. Journal of International Economics 1994;37:167-95 [DOI:10.1016/0022-1996(94)90044-2]
45. Hausman JA, MacKie-Mason JK. Price discrimination and patent policy. The RAND Journal of Economics 1988; 19:253-65 [DOI:10.2307/2555703]
46. Younessi DN, Lin JC, Greenberg PB, French DD. Correlates of price transparency for healthcare services in United States hospitals. ClinicoEconomics and Outcomes Research 2022; 14:601-606 [DOI:10.2147/CEOR.S378475]
47. Garattini L, Cornago D, De Compadri P. Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis. Health Policy 2007;82:330-9 [DOI:10.1016/j.healthpol.2006.11.004]
48. Mosadeghrad AM, Comments on Iran hospital accreditation system, Iranian Journal of Public Health 2016; 45: 837-842
49. Calfee JE. The increasing necessity for market-based pharmaceutical prices. Pharmacoeconomics 2000;18:47-57 [DOI:10.2165/00019053-200018001-00007]
50. McGuire TG, Glazer J, Newhouse JP, Normand SL, Shi J, Sinaiko AD, Zuvekas SH. Integrating risk adjustment and enrollee premiums in health plan payment. Journal of Health Economics 2013;32:1263-77 [DOI:10.1016/j.jhealeco.2013.05.002]
51. Ding H, Duggan M, Starc A. Getting the price right? The impact of competitive bidding in the Medicare program. Review of Economics and Statistics 2022:1: 1-45 [DOI:10.1162/rest_a_01249]
52. Ghiasipour M, Mosadeghrad AM, Arab M, Jaafaripooyan E. Leadership challenges in health care organizations: The case of Iranian hospitals. Medical journal of the Islamic Republic of Iran 2017; 31: 560-567 [DOI:10.14196/mjiri.31.96]
53. Esfahani P, Mosadeghrad AM, Akbarisari A. The success of strategic planning in health care organizations of Iran. International Journal of Health Care Quality Assurance 2018;31:563-74 [DOI:10.1108/IJHCQA-08-2017-0145]
54. Mosadeghrad AM, Ferlie E. Total quality management in healthcare. In Management Innovations for Healthcare Organizations 2015 (pp. 378-396). 1st Edition, Routledge: New York
55. Guinness L, Ghosh S, Mehndiratta A, et al. Role of healthcare cost accounting in pricing and reimbursement in low- income and middle- income countries: a scoping review. BMJ Open 2022;12:e065019 [DOI:10.1136/bmjopen-2022-065019]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |